What federal testing has found
The most comprehensive look at PFAS in tap water comes from a U.S. Geological Survey study led by researcher Kelly Smalling and published in the peer-reviewed journal Environment International. The team collected samples from 716 locations, testing for 32 individual PFAS compounds. Detections turned up in urban centers and farming communities at comparable rates, reinforcing concerns that these synthetic chemicals, used in nonstick coatings, firefighting foam, and food packaging, have spread far beyond the industrial sites where contamination was first identified decades ago. “The results underscore that PFAS contamination is not confined to known pollution sites,” said Kelly Smalling, the USGS research hydrologist who led the study. “It is a national issue affecting both public and private water supplies.” The EPA has been building on that picture through its Fifth Unregulated Contaminant Monitoring Rule, known as UCMR 5. The program required public water systems to sample for 29 PFAS compounds plus lithium between January 2023 and December 2025. That sampling window has now closed, and systems and laboratories have been submitting results following EPA reporting guidance that standardizes facility identifiers, sampling codes, measured values, and lab credentials. As of spring 2026, the EPA maintains a public Data Finder tool that links individual system results to health-based reference points and, for regulated PFAS, to the new federal maximum contaminant levels. On April 10, 2024, the EPA finalized its PFAS National Primary Drinking Water Regulation, setting enforceable limits on six specific PFAS compounds. The rule establishes individual maximum contaminant levels for PFOA and PFOS at 4 parts per trillion each and introduces a hazard index approach for mixtures of four additional compounds: PFNA, PFHxS, PFBS, and GenX chemicals. It was the first time the federal government moved PFAS oversight from advisory guidance into a legally binding framework that can require treatment upgrades or other corrective actions. Public water systems must comply between 2027 and 2029, depending on system size. The disease surveillance side of the picture runs through the CDC’s National Wastewater Surveillance System. The NWSS program collects wastewater data from treatment plants and other collection points nationwide, converting sewage into community-level samples that reveal trends in pathogen circulation. Originally scaled up during the COVID-19 pandemic, the network now tracks multiple targets, including influenza, RSV, and norovirus, giving public health agencies early warning before clinical testing captures the full scope of an outbreak. A CDC study published in the Morbidity and Mortality Weekly Report in January 2024 examined how effectively wastewater testing detected mpox cases between August 2022 and May 2023. The analysis calculated the probability of picking up monkeypox virus in sewage given different numbers of people actively shedding the virus. Researchers found that wastewater surveillance identified viral signals even when reported case counts were low, supporting its role as a complement to clinical reporting and a tool for catching outbreaks early.What remains uncertain
Significant gaps remain. Although UCMR 5 sampling concluded in December 2025, the full dataset is still being compiled and reviewed as of May 2026. Results published so far represent a partial picture, and national contamination patterns could shift as final submissions are processed. The EPA’s occurrence data provides system-level results, but aggregated summaries do not always show which specific neighborhoods face the highest concentrations or which treatment methods are proving most effective against different PFAS compounds. The new PFAS drinking water rule also faces legal uncertainty. Industry groups, including the American Water Works Association, have challenged the regulation in federal court, arguing that compliance costs for smaller utilities could be prohibitive and that the science underlying certain limits needs further review. The outcome of that litigation, combined with any shifts in enforcement priorities under changing EPA leadership, could affect how quickly the standards translate into cleaner tap water. Direct statements from water utility operators about how they plan to respond to UCMR 5 detections remain scarce in the public record. The EPA provides institutional guidance, but individual compliance plans, cost estimates for treatment upgrades, and timelines for reducing PFAS levels have not been widely disclosed. For the tens of millions of Americans who rely on smaller water systems or private wells, the path from detection to remediation is even murkier. Private wells fall outside the federal regulatory framework governing public supplies and typically depend on state rules or homeowner initiative. On the infectious disease front, the CDC’s wastewater program has proven it can detect pathogen signals at scale. But the relationship between environmental chemical exposure and disease vulnerability has not been established through any integrated federal dataset. PFAS monitoring and wastewater disease tracking operate as separate programs with distinct methodologies, sampling locations, and reporting structures. No published federal analysis has connected geographic PFAS contamination hotspots to heightened rates of infectious disease in those same communities. Whether such a correlation exists, and whether PFAS exposure weakens immune response enough to affect disease outcomes at a population level, are open scientific questions that current data cannot resolve. Representation is another concern. UCMR 5 focuses on public water systems above certain size thresholds, leaving many very small systems and private wells outside its scope. Wastewater monitoring depends on participating utilities and local health departments, which means some rural or unsewered communities may not appear in national dashboards. Both chemical and biological risks could be under-counted in places with limited infrastructure or fewer resources for sampling.How to use the evidence
Readers evaluating these findings should distinguish between two tiers of evidence. The USGS tap water study and the CDC mpox wastewater research are both peer-reviewed, meaning their methods, assumptions, and limitations were examined by independent scientists before publication. These represent the strongest available evidence for their respective claims about PFAS prevalence and wastewater surveillance sensitivity. The EPA’s UCMR 5 occurrence data sits in a different category. It is primary federal data collected under a formal regulatory program, publicly accessible and standardized for independent verification. But interpreting raw detection numbers requires understanding minimum reporting levels, analytical methods, and the difference between a detection and a health risk exceedance. The EPA’s Data Finder tool helps by linking results to health-based benchmarks, though users should read the accompanying technical documentation and recognize that a non-detect does not always mean a chemical is entirely absent. For anyone served by a public water system, the most direct step is to search the EPA’s UCMR 5 Data Finder using a local system name or ID number. The tool shows whether a system has been sampled, what was detected, and how results compare to federal health reference points. Residents on private wells face a harder path. The USGS research confirmed that PFAS appear in private well water at rates comparable to public supplies, which means well owners who want answers will need to arrange independent testing through a certified laboratory. Point-of-use treatment systems, such as reverse osmosis or granular activated carbon filters certified for PFAS removal, are options where contamination is confirmed, though costs vary widely. The federal government is now operating two distinct but related surveillance capabilities: one tracking chemicals that persist in drinking water, the other tracking pathogens moving through wastewater. Each offers an early warning function. PFAS monitoring can reveal long-term contamination before health standards are exceeded. Sewage testing can flag emerging outbreaks before emergency rooms fill up. But the programs remain largely siloed, run by different agencies with separate funding streams and data platforms. For now, the clearest takeaway from the available evidence is that water systems across the country are carrying multiple kinds of risk at once. Sustained monitoring, transparent disclosure of results, and targeted investment in treatment and infrastructure will be essential as the final UCMR 5 data comes into focus and the first compliance deadlines for the PFAS drinking water rule approach in 2027. More from Morning Overview*This article was researched with the help of AI, with human editors creating the final content.
